Understanding the Challenge
Accessing health data for AI development is difficult. Patient privacy, regulations, and intellectual property concerns often keep valuable information locked away. This situation limits the potential of AI in life sciences and pharmaceuticals. Apheris, a startup led by Robin Röhm, is tackling this issue through a method called federated computing. This approach allows AI models to be trained without moving sensitive data, thus maintaining privacy and security.
Key Insights
- Apheris has secured $8.25 million in Series A funding, bringing total funding to $20.8 million.
- The company’s software, Apheris Compute Gateway, connects local data with AI models safely.
- Major clients include Roche and various hospitals, indicating strong market interest.
- The startup has shifted its focus from federated learning to serving data owners in the pharma sector, resulting in a fourfold revenue increase.
The Bigger Picture
Apheris is positioned to become vital in emerging federated data networks. By enabling secure collaboration, it can unlock the potential of AI in drug discovery and other life sciences applications. Addressing data owners’ concerns is crucial for maximizing AI’s impact, and Apheris is committed to making this happen. As the ecosystem matures, tools like Apheris will play a significant role in advancing healthcare innovation.
